Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Study completedNCT00006357What this trial is testingSTI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaWho this might be right forEndometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00390234What this trial is testingZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaWho this might be right forFallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)Ended earlyNCT03610490What this trial is testingAutologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal AdenocarcinomaWho this might be right forMalignant Solid NeoplasmMetastatic Colorectal AdenocarcinomaMetastatic Ovarian Carcinoma+9 more M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)WithdrawnNCT06393751What this trial is testingTesting the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian CancerWho this might be right forPlatinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT03651206What this trial is testingRecurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibWho this might be right forOvarian CarcinosarcomaEndometrial Carcinosarcoma ARCAGY/ GINECO GROUP 138
Testing effectiveness (Phase 2)Study completedNCT00245102What this trial is testingSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaWho this might be right forAdult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more National Cancer Institute (NCI) 147
Large-scale testing (Phase 3)Study completedNCT00002641What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 350
Testing effectiveness (Phase 2)Study completedNCT03395080What this trial is testingDKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or CarcinosarcomaWho this might be right forEndometrial CancerUterine CancerOvarian Cancer+1 more Leap Therapeutics, Inc. 111
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Early research (Phase 1)Active Not RecruitingNCT05691504What this trial is testingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersWho this might be right forAdvanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00352300What this trial is testingCarboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerWho this might be right forFallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more Gynecologic Oncology Group 43
Testing effectiveness (Phase 2)Study completedNCT03648489What this trial is testingDual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinosarcoma+7 more Imperial College London 134
Early research (Phase 1)Ended earlyNCT03924245What this trial is testingOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersWho this might be right forFallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108What this trial is testingLN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasWho this might be right forBone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05920798What this trial is testingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CarcinosarcomaPrimary Peritoneal CarcinosarcomaRecurrent Fallopian Tube Carcinoma+13 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00003939What this trial is testingEcteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaWho this might be right forBrain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more European Organisation for Research and Treatment of Cancer - EORTC 132
Testing effectiveness (Phase 2)Looking for participantsNCT06639074What this trial is testingFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT TrialWho this might be right forAdvanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian Carcinoma+15 more Mayo Clinic 78
Testing effectiveness (Phase 2)WithdrawnNCT03933761What this trial is testingPamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or ChemotherapyWho this might be right forOvarian CancerCarcinosarcoma Australia New Zealand Gynaecological Oncology Group